Bend, OR, United States of America

Mark D Rabenstein

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mark D Rabenstein

Introduction

Mark D Rabenstein is a notable inventor based in Bend, OR (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug solubility. With a total of 2 patents, Rabenstein's work is recognized for its potential impact on drug delivery systems.

Latest Patents

Rabenstein's latest patents focus on pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials. These compositions comprise a solid amorphous dispersion that includes a low-solubility drug and a concentration-enhancing polymer, along with a lipophilic microphase-forming material. This innovative approach allows for improved drug solubility and bioavailability, which is crucial for effective treatment outcomes.

Career Highlights

Throughout his career, Rabenstein has been associated with Bend Research, Inc., where he has been instrumental in advancing pharmaceutical technologies. His expertise in creating effective drug formulations has positioned him as a valuable asset in the research and development sector.

Collaborations

Rabenstein has collaborated with several professionals in his field, including Michael E Perlman and Ravi Mysore Shanker. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Mark D Rabenstein's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in drug formulation, making him a key figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…